1,666
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Regulation of CD1, Ki-67, PCNA mRNA expression, and Akt activation in estrogen-responsive human breast adenocarcinoma cell line, MCF-7 cells, by griffonianone C, an isoflavone derived from Millettia griffoniana

, , , &
Pages 341-347 | Received 10 Mar 2010, Accepted 17 Aug 2010, Published online: 02 Feb 2011

References

  • Beyer C. (1999). Estrogen and the developing mammalian brain. Anat Embryol, 199, 379–390.
  • Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL. (1993). Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8, 2127–2133.
  • Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318–1321.
  • Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. (1997). Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231–241.
  • DeMayo FJ, Zhao B, Takamoto N, Tsai SY. (2002). Mechanisms of action of estrogen and progesterone. Ann N Y Acad Sci, 955, 48–59; discussion 86.
  • Enmark E, Gustafsson JA. (1999). Oestrogen receptors - an overview. J Intern Med, 246, 133–138.
  • Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M. (2000). Multiple actions of steroid hormones–a focus on rapid, nongenomic effects. Pharmacol Rev, 52, 513–556.
  • Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol, 133, 1710–1715.
  • Gong L, Li Y, Nedeljkovic-Kurepa A, Sarkar FH. (2003). Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene, 22, 4702–4709.
  • Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. (1986). Sequence and expression of human estrogen receptor complementary DNA. Science, 231, 1150–1154.
  • Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. (2002). Production and actions of estrogens. N Engl J Med, 346, 340–352.
  • Guzeloglu Kayisli O, Kayisli UA, Luleci G, Arici A. (2004). In vivo and in vitro regulation of Akt activation in human endometrial cells is estrogen dependent. Biol Reprod, 71, 714–721.
  • Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR. (2000). Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res, 87, 677–682.
  • Helguero LA, Faulds MH, Gustafsson JA, Haldosén LA. (2005). Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene, 24, 6605–6616.
  • Hui R, Cornish AL, McClelland RA, Robertson JF, Blamey RW, Musgrove EA, Nicholson RI, Sutherland RL. (1996). Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clin Cancer Res, 2, 923–928.
  • Iatropoulos MJ, Williams GM. (1996). Proliferation markers. Exp Toxicol Pathol, 48, 175–181.
  • Kane LP, Shapiro VS, Stokoe D, Weiss A. (1999). Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol, 9, 601–604.
  • Ketcha Wanda GJM, Njamen D, Yankep E, Fotsing MT, Fomum ZT, Wober J, Starcke S, Zierau O, Vollmer G. (2006). Estrogenic properties of isoflavones derived from Millettia griffoniana. Phytomedicine, 13, 139–145.
  • Klotz DM, Hewitt SC, Ciana P, Raviscioni M, Lindzey JK, Foley J, Maggi A, DiAugustine RP, Korach KS. (2002). Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J Biol Chem, 277, 8531–8537.
  • Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA, 93, 5925–5930.
  • Levin ER. (2001). Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol, 91, 1860–1867.
  • Musgrove EA, Hamilton JA, Lee CS, Sweeney KJ, Watts CK, Sutherland RL. (1993). Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol, 13, 3577–3587.
  • Sanchez R, Nguyen D, Rocha W, White JH, Mader S. (2002). Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays, 24, 244–254.
  • Urruticoechea A, Smith IE, Dowsett MJ. (2005). Proliferation marker Ki-67 in early breast cancer. J Clin Oncol, 23, 7212–7220.
  • Wang CY, Mayo MW, Baldwin AS Jr. (1996). TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science, 274, 784–787.
  • Watts CK, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL. (1995). Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol Endocrinol, 9, 1804–1813.
  • Winer J, Jung CK, Shackel I, Williams PM. (1999). Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem, 270, 41–49.
  • Yankep E, Mbafor JT, Fomum ZT, Steinbeck C, Messanga BB, Nyasse B, Budzikiewicz H, Lenz C, Schmickler H. (2001). Further isoflavonoid metabolites from Millettia griffoniana (Bail). Phytochemistry, 56, 363–368.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.